Actigen Ltd Report issue

For profit Phase 1 Phase 3
Founded: Oslo Norway (1997)
Status: Acquired by Affitech AS (2000)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (2)

Key: Actigen Ltd (0) Acquired (2)

gemcitabine (gemzar) (1 trial)

gv 1001 (2 trials)

Drugs in Phase 1 Trials (1)

Key: Actigen Ltd (0) Acquired (1)

ep1090 (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 3
  • # of Trial APIs: 3